[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"article-17c0ccb5-0661-41ce-ba9e-b6af3380c7f2--":3,"related-articles-undefined-undefined-fa8425a2-4727-4222-9162-96a79183b206-true":18},{"id":4,"type":5,"title":6,"pubDate":7,"logoUrl":8,"organisationTitle":9,"thirdParty":10,"body":11,"imageUrls":12,"city":14,"website":15,"orgId":16,"description":17},"17c0ccb5-0661-41ce-ba9e-b6af3380c7f2","PRESSRELEASE","Patiënt moet meer op de voorgrond bij centralisatie van zorg","2018-04-18T09:57:54.011+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Ffile\u002Flogos\u002Ffa8425a2-4727-4222-9162-96a79183b206\u002F630d374a-5754-4901-ac6b-9be8155c2a1a.jpg","ECORYS Nederland B.V.",false,"\u003Cp>\u003Cstrong>Ecorys heeft onderzoek gedaan naar de effecten van centralisatie van zorg rondom innovatieve geneesmiddelen binnen de oncologie (o.a. bij immuuntherapie). In haar studie constateert Ecorys dat het zorgveld ziet dat centralisatie leidt tot kwaliteitswinst en expertisebundeling. Echter, een opvallende bevinding is dat de patiënt onvoldoende als partner betrokken wordt bij het proces. Aansluitend geeft een ruime meerderheid van de artsen aan dat centralisatie van zorg een negatief effect heeft op de toegang tot zorg voor de patiënt. \u003C\u002Fstrong>\u003C\u002Fp>\n\u003Cp>\u003Cstrong> \u003C\u002Fstrong>\u003C\u002Fp>\n\u003Cp>\u003Cstrong>Bevindingen\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Cp>Het onderzoek van Ecorys laat zien dat tegenstrijdige belangen ontstaan (zoals beperken van zorguitgaven, strategische positionering ziekenhuizen, en werkbehoud\u002F-beleving van specialisten) tussen de verschillende betrokken partijen, wat de toegang tot deze gecentraliseerde zorg kan belemmeren voor de patiënt.\u003C\u002Fp>\n\u003Cp>In opdracht voerde Kantar Public een aanvullend onderzoek uit onder ruim 200 specialisten om hun visie te peilen. Specialisten zijn verdeeld in hun sentiment ten aanzien van de manier waarop centralisatie van zorg rondom innovatieve geneesmiddelen wordt vormgegeven in Nederland. Ook in dit onderzoek komt sterk naar voren dat er meer aandacht nodig is voor de patiënt. Ruim vier op de tien van de ondervraagde specialisten vinden dat de patiënt momenteel onvoldoende centraal staat. Eveneens vindt ruim de helft van de ondervraagde specialisten dat centralisatie een negatieve invloed heeft op de toegankelijkheid van zorg.\u003C\u002Fp>\n\u003Cp>\u003Cstrong>Oplossingsrichtingen\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Cp>Vanuit het onderzoek worden verschillende oplossingsrichtingen aangedragen. Dit zijn onder andere het ontwikkelen van een gedeelde visie en heldere, objectieve criteria voor centralisatie van zorg rondom innovatieve geneesmiddelen waarin het belang van de patiënt centraal gesteld wordt, het (al in een vroeg stadium) betrekken van patiëntenverenigingen in het proces van centralisatie, en het werken aan een manier om de daadwerkelijke effecten van centralisatie (zoals de impact op doelmatigheid en kwaliteit van zorg) inzichtelijk te maken. Tevens kan de overheid randvoorwaarden scheppen en\u002Fof aanscherpen om de aanbevolen oplossingen te faciliteren en ervoor te zorgen dat alle partijen samenwerken en verantwoordelijkheid nemen.\u003C\u002Fp>\n\u003Cp>\u003Cstrong>Achtergrond \u003C\u002Fstrong>\u003C\u002Fp>\n\u003Cp>Ecorys heeft onderzocht wat de positieve en\u002Fof negatieve effecten en ervaringen kunnen zijn als gevolg van centralisatie van zorg rondom innovatieve geneesmiddelen binnen de oncologie, in opdracht van Bristol-Myers Squibb (B-MS). In dit breed verkennend onderzoek zijn de ervaringen van koepelorganisaties, medisch specialisten, beroepsgroepen, zorgverzekeraars, patiënten, en RvB’s van ziekenhuizen in kaart gebracht. Vervolgens heeft Kantar Public, ook in opdracht van B-MS, aanvullend kwantitatief onderzoek gedaan onder een brede groep medisch specialisten. Een gezamenlijke factsheet is gepubliceerd met de belangrijkste resultaten uit deze onderzoeken. Op woensdag 18 april organiseren Ecorys en B-MS een bijeenkomst in Nieuwspoort en worden de gemeenschappelijke onderzoeksresultaten gepresenteerd en bediscussieerd met directe belanghebbenden.\u003C\u002Fp>\n\u003Cp>\u003Cem>Klik hier voor het rapport ‘Onderzoek naar de effecten van centralisatie van zorg rondom innovatieve geneesmiddelen’.\u003C\u002Fem>\u003C\u002Fp>\n\u003Cp>\u003Cem>Klik hier voor het rapport van Kantar Public.\u003C\u002Fem>\u003C\u002Fp>\n\u003Cp>\u003Cem>Klik hier voor de factsheet ‘Centralisatie van zorg rondom innovatieve geneesmiddelen’.\u003C\u002Fem>\u003C\u002Fp>",[13],"https:\u002F\u002Flh3.googleusercontent.com\u002FtyBlHI92OcJHKwtSv4Sxj524imgWR3JvKv_1BIqxZkUw6bC7Y6XctxaTVEAmilx3Y5WgTXIAPz0rSnqxrREj6YXaphLmKGVsjQ","Rotterdam","https:\u002F\u002Fwww.ecorys.nl\u002F","fa8425a2-4727-4222-9162-96a79183b206","Ecorys heeft onderzoek gedaan naar de effecten van centralisatie van zorg rondom innovatieve geneesmiddelen binnen de oncologie (o.a. bij immuuntherapie). In ha",[19,24,39,46,475,477],{"id":20,"title":21,"pubDate":22,"logoUrl":8,"thirdParty":10,"orgId":16,"description":23},"2b38958b-8cc6-4f93-b4f6-f5780ee3e9ef","Dr. Brigitte Slot nieuwe algemeen directeur Ecorys Nederland","2020-11-30T15:23:32.836+01:00","Ecorys heeft dr. Brigitte Slot benoemd tot algemeen directeur van Ecorys Nederland. Zij volgt per 1 december 2020 Marien van Riessen op, die na ruim vier jaar d",{"id":25,"title":26,"pubDate":27,"logoUrl":8,"thirdParty":10,"imageUrls":28,"orgId":16,"branches":30,"description":38},"0cc8f64c-77a2-4d19-ae10-4a73dc5c3048","Kringloopwinkels leveren positieve impact op mens en milieu","2020-11-09T10:22:26.218+01:00",[29],"https:\u002F\u002Forder.perssupport.nl\u002Ffile\u002Fpressrelease\u002Ffa8425a2-4727-4222-9162-96a79183b206\u002F0cc8f64c-77a2-4d19-ae10-4a73dc5c3048\u002FKringloopwinkelsleverenpositieveimpactopmensenmilieu.pdf",[31,35],{"id":32,"title":33,"parentId":34},"23109","Afvalverwerking en -hergebruik","23100",{"id":36,"title":37,"parentId":34},"23108","Recycling","In kringloopwinkels krijgen zowel spullen als mensen een tweede kans. Daarom zijn ze belangrijk voor onze maatschappij. Ecorys bracht in samenwerking met de Bra",{"id":40,"title":41,"pubDate":42,"logoUrl":8,"thirdParty":10,"imageUrls":43,"orgId":16,"description":45},"92b3215d-c4f8-436d-a95e-f8597e71a287","Ecorys brengt financiële gevolgen van de warmtetransitie in kaart","2019-03-29T09:55:26.731+01:00",[44],"https:\u002F\u002Forder.perssupport.nl\u002Ffile\u002Fpressrelease\u002Ffa8425a2-4727-4222-9162-96a79183b206\u002F92b3215d-c4f8-436d-a95e-f8597e71a287\u002F20190220DefinancielegevolgenvandewarmtetransitieEindrapport.pdf","Ecorys is door Milieudefensie gevraagd om een studie te doen naar de financiële gevolgen van de warmtetransitie. Daarbij is gekeken naar de kosten en financieri",{"id":47,"title":48,"pubDate":49,"logoUrl":8,"thirdParty":10,"orgId":16,"branches":50,"description":474},"a0155c3f-4368-4905-ab69-ebf8273829d3","Ecorys analyseert coalitieakkoorden van 45 gemeenten","2018-08-09T14:36:46.686+02:00",[51,55,58,61,64,67,70,73,76,79,82,85,88,91,94,98,101,104,107,110,113,116,119,122,125,128,131,134,137,140,143,146,149,152,155,158,161,164,167,170,173,176,179,182,185,188,191,194,197,200,203,206,210,213,216,219,222,225,228,231,234,237,240,243,246,249,252,255,258,261,264,267,270,273,275,279,282,285,289,292,295,298,301,304,307,310,313,316,319,322,325,328,331,334,337,340,343,346,349,352,355,358,361,363,366,369,372,375,378,381,384,387,390,393,396,399,402,405,408,411,414,417,420,423,426,430,433,436,439,442,445,448,451,454,457,460,463,466,469,472],{"id":52,"title":53,"parentId":54},"26155","Effecten en aandelen","26100",{"id":56,"title":57,"parentId":54},"26101","Accountancy",{"id":59,"title":60,"parentId":54},"93532","Beleggingen en investeringen",{"id":62,"title":63,"parentId":54},"26133","Amerikaanse obligaties",{"id":65,"title":66,"parentId":54},"26103","Banken",{"id":68,"title":69,"parentId":54},"26151","Banken en financiële instellingen",{"id":71,"title":72,"parentId":54},"26108","Bedrijfsobligaties",{"id":74,"title":75,"parentId":54},"26147","Belastingen",{"id":77,"title":78,"parentId":54},"26149","Beleggingsfondsen",{"id":80,"title":81,"parentId":54},"26134","Beleggingsmaatschappijen",{"id":83,"title":84,"parentId":54},"26157","Bijzondere situaties",{"id":86,"title":87,"parentId":54},"93912","Converteerbare obligaties en aandelen",{"id":89,"title":90,"parentId":54},"26148","Valutas",{"id":92,"title":93,"parentId":54},"93922","Derivaten",{"id":95,"title":96,"parentId":97},"26112","E-commerce","12109",{"id":99,"title":100,"parentId":54},"26159","E-marktspelers",{"id":102,"title":103,"parentId":54},"26113","Economie",{"id":105,"title":106,"parentId":54},"93932","Effecten",{"id":108,"title":109,"parentId":54},"26146","Effectenbeurs",{"id":111,"title":112,"parentId":54},"26115","Euro-obligaties",{"id":114,"title":115,"parentId":54},"26116","Euromarkten",{"id":117,"title":118,"parentId":54},"26119","Financieel directeurs",{"id":120,"title":121,"parentId":54},"26120","Financiële dienstverlening",{"id":123,"title":124,"parentId":54},"26121","Financiële technologie",{"id":126,"title":127,"parentId":54},"26118","Financiën",{"id":129,"title":130,"parentId":54},"26136","Financiën in het buitenland",{"id":132,"title":133,"parentId":54},"26144","Fondsen",{"id":135,"title":136,"parentId":54},"93972","Fondsenbeheer",{"id":138,"title":139,"parentId":97},"26130","Fusies en overnames",{"id":141,"title":142,"parentId":54},"26111","Gediversifieerde bedrijven",{"id":144,"title":145,"parentId":54},"26102","Geldautomaten",{"id":147,"title":148,"parentId":54},"26131","Geldmarkten",{"id":150,"title":151,"parentId":54},"26107","Goederen",{"id":153,"title":154,"parentId":54},"93542","Hedge funds",{"id":156,"title":157,"parentId":54},"93212","Herverzekering",{"id":159,"title":160,"parentId":54},"26128","Huurkoop",{"id":162,"title":163,"parentId":54},"26106","Hypotheekbanken",{"id":165,"title":166,"parentId":54},"26132","Hypotheken",{"id":168,"title":169,"parentId":54},"26125","Internationale beurzen",{"id":171,"title":172,"parentId":54},"26124","Internationale financiën",{"id":174,"title":175,"parentId":54},"26154","Internationale fondsen",{"id":177,"title":178,"parentId":54},"26126","Investeringen",{"id":180,"title":181,"parentId":54},"26153","Investeringsbanken",{"id":183,"title":184,"parentId":54},"26127","Investeringstrustmaatschappijen",{"id":186,"title":187,"parentId":54},"93552","Islamfondsen",{"id":189,"title":190,"parentId":54},"26109","Krediet en huurkoop",{"id":192,"title":193,"parentId":54},"93572","Kredietbeheer",{"id":195,"title":196,"parentId":54},"26110","Kredietkaarten",{"id":198,"title":199,"parentId":54},"26158","Kredietverenigingen",{"id":201,"title":202,"parentId":54},"26156","Leningen",{"id":204,"title":205,"parentId":54},"26138","Loonlijst en salarissen",{"id":207,"title":208,"parentId":209},"26105","Woningmarkt en makelaardij","42100",{"id":211,"title":212,"parentId":54},"93562","Managed currency funds",{"id":214,"title":215,"parentId":54},"26135","Nieuwe financiering",{"id":217,"title":218,"parentId":54},"26104","Obligatiebeheer",{"id":220,"title":221,"parentId":54},"26114","Opkomende markten",{"id":223,"title":224,"parentId":54},"26129","Opkoping door het bestuur of met geleend geld",{"id":226,"title":227,"parentId":54},"26137","Opties en termijnzaken",{"id":229,"title":230,"parentId":54},"93952","Particuliere bankwezen",{"id":232,"title":233,"parentId":54},"93962","Particuliere effecten",{"id":235,"title":236,"parentId":54},"26139","Pensioenen en uitkeringen",{"id":238,"title":239,"parentId":54},"26140","Persoonlijke financiën",{"id":241,"title":242,"parentId":54},"26141","Persoonlijke-financiënindustrie",{"id":244,"title":245,"parentId":54},"26143","Portefeuillebeheerder",{"id":247,"title":248,"parentId":54},"26142","Privé-spaargeld",{"id":250,"title":251,"parentId":54},"26150","Risicodragend kapitaal",{"id":253,"title":254,"parentId":54},"93582","Schulden en schuldenregeling",{"id":256,"title":257,"parentId":54},"26145","Smartcards",{"id":259,"title":260,"parentId":54},"26122","Staatsobligaties",{"id":262,"title":263,"parentId":54},"93222","Vast kapitaal",{"id":265,"title":266,"parentId":54},"26152","Vennootschappen",{"id":268,"title":269,"parentId":54},"26123","Verzekeringen",{"id":271,"title":272,"parentId":54},"93942","Vreemde valuta",{"id":54,"title":274},"Economie en geld",{"id":276,"title":277,"parentId":278},"41103","Actualiteiten","28100",{"id":280,"title":281,"parentId":278},"41109","Binnenlandse zaken",{"id":283,"title":284,"parentId":278},"41107","Buitenlandse zaken",{"id":286,"title":287,"parentId":288},"41101","Burgerrechten","41100",{"id":290,"title":291,"parentId":288},"41102","Commonwealth",{"id":293,"title":294,"parentId":288},"41104","Diplomatieke dienst",{"id":296,"title":297,"parentId":288},"41105","Europese Unie",{"id":299,"title":300,"parentId":288},"41106","Feminisme",{"id":302,"title":303,"parentId":288},"93732","Fiscale politiek",{"id":305,"title":306,"parentId":278},"41110","Immigratie & migratie",{"id":308,"title":309,"parentId":278},"41115","Koninklijk huis",{"id":311,"title":312,"parentId":278},"93712","Mensenrechten",{"id":314,"title":315,"parentId":288},"41111","Nucleaire ontwapening",{"id":317,"title":318,"parentId":288},"11014","Onderzoeksjournalistiek",{"id":320,"title":321,"parentId":288},"93702","Ontwikkelingspolitiek en buitenlandse hulp",{"id":323,"title":324,"parentId":288},"11015","Opinie",{"id":326,"title":327,"parentId":288},"41108","Overheid",{"id":329,"title":330,"parentId":288},"41112","Partijpolitiek",{"id":332,"title":333,"parentId":278},"41113","Politiek",{"id":335,"title":336,"parentId":288},"41118","Politiek en actualiteiten - andere",{"id":338,"title":339,"parentId":288},"75c894e5-ad7f-494f-ae46-824554ba965d","Politieke jongeren organisaties (PJO)",{"id":341,"title":342,"parentId":288},"41114","Rassenrelaties",{"id":344,"title":345,"parentId":288},"41116","Satire",{"id":347,"title":348,"parentId":288},"93722","Seksuele gelijkheid",{"id":350,"title":351,"parentId":288},"41117","Sociaal activisme",{"id":353,"title":354,"parentId":288},"94882","Sociaal beleid",{"id":356,"title":357,"parentId":288},"789dc005-3017-4e5e-8310-7b2daff9aab9","Terrorisme",{"id":359,"title":360,"parentId":278},"93742","Verkiezingen",{"id":288,"title":362},"Politiek en actualiteiten",{"id":364,"title":365,"parentId":209},"42109","Woningen",{"id":367,"title":368,"parentId":278},"28119","Administratie van de openbare sector",{"id":370,"title":371,"parentId":278},"28103","Ambtenarij",{"id":373,"title":374,"parentId":278},"28110","Bibliotheken en informatiesystemen",{"id":376,"title":377,"parentId":278},"93602","Brandweer",{"id":379,"title":380,"parentId":278},"28129","Congres",{"id":382,"title":383,"parentId":278},"28106","Consumentenbescherming",{"id":385,"title":386,"parentId":278},"28107","Counseling",{"id":388,"title":389,"parentId":278},"28131","Digitale overheid",{"id":391,"title":392,"parentId":278},"28104","Gemeenschapsontwikkeling",{"id":394,"title":395,"parentId":278},"28105","Gemeenschapstransport",{"id":397,"title":398,"parentId":278},"28115","Gevangeniswezen",{"id":400,"title":401,"parentId":278},"28101","Grenzen en douane",{"id":403,"title":404,"parentId":278},"28130","Hooggerechtshof",{"id":406,"title":407,"parentId":278},"28112","Huwelijksbegeleiding",{"id":409,"title":410,"parentId":278},"28102","Kinderopvang",{"id":412,"title":413,"parentId":278},"28132","Mededelingen van de overheid",{"id":415,"title":416,"parentId":278},"28127","Nationale overheid",{"id":418,"title":419,"parentId":278},"28125","Ontwikkeling en welzijn van kinderen",{"id":421,"title":422,"parentId":278},"28118","Openbare financiën",{"id":424,"title":425,"parentId":278},"28117","Openbare voorzieningen",{"id":427,"title":428,"parentId":429},"28120","Openbare werken","51000",{"id":431,"title":432,"parentId":278},"28133","Overheidsdiensten",{"id":434,"title":435,"parentId":278},"28134","Overheidsdiensten - andere",{"id":437,"title":438,"parentId":278},"28109","Overheidsinformatie",{"id":440,"title":441,"parentId":278},"28111","Politieke partijen",{"id":443,"title":444,"parentId":278},"28114","Politie",{"id":446,"title":447,"parentId":278},"28108","Provinciale besturen en districtsraden",{"id":449,"title":450,"parentId":278},"28126","Regionale overheid",{"id":452,"title":453,"parentId":278},"28128","Regulerende overheidsdiensten",{"id":455,"title":456,"parentId":278},"28123","Sociaal werk",{"id":458,"title":459,"parentId":278},"28122","Sociale diensten",{"id":461,"title":462,"parentId":278},"28124","Stadsplanning en -beleid",{"id":464,"title":465,"parentId":278},"28121","Taxatiewaarde",{"id":467,"title":468,"parentId":278},"28113","Techniek en uitrusting op gemeentelijk vlak",{"id":470,"title":471,"parentId":278},"28116","Voorwaardelijke invrijheidsstelling",{"id":278,"title":473},"Politiek en overheid","Op 21 maart 2018 vonden er gemeenteraadsverkiezingen plaats in 335 van de 380 Nederlandse gemeenten. Door de jaren heen hebben gemeenten een steeds uitgebreider",{"id":4,"title":6,"pubDate":7,"logoUrl":8,"thirdParty":10,"imageUrls":476,"orgId":16,"description":17},[13],{"id":478,"title":479,"pubDate":480,"logoUrl":8,"thirdParty":10,"imageUrls":481,"orgId":16,"description":483},"a703f2e1-2c17-467b-aebe-7433768e0fa7","Michel van Woesik to join Ecorys' Board of Management","2018-03-20T13:43:40.965+01:00",[482],"https:\u002F\u002Flh3.googleusercontent.com\u002FxMUXP9x2CN9Tlobe9fXkwFVzcEuGo447zztIW5ts7aLNtmzR3Exc-dLxIS7a2xEsAof2tEISWaG88xR5x648B2YrzG_3h4ieug","Ecorys is delighted to announce the appointment of Michel van Woesik as Chief Financial Officer and member of the Ecorys Board of Management per 1 April 2018. M"]